Search





Search





News

All

Editors' Picks

Stocks

Indices

Market Movers

Commodities

Cryptocurrencies

Forex

Presentations

Earnings

Transcripts

Technical Analysis

Economic Indicator

Other

SBC Medical Q2 2026 Earnings Call: EBITDA Rises 32% as Growth Reaccelerates

SBC Medical's Q2 2026 earnings call covered 13% revenue growth, 32% adjusted EBITDA growth, AI deployment and a planned $15 million fee uplift.

SBC Medical Group Holdings Inc

TradingKey

Fri, Aug 14

Stardust Power (SDST) Q2 2026 Earnings Call: Liquidity and Refinery Financing in Focus

Stardust Power’s Q2 2026 earnings call covered a $3.9 million net loss, $0.5 million cash balance, new equity facilities and progress toward financing the Muskogee lithium refinery.

Stardust Power Inc

TradingKey

Fri, Aug 14

Red Robin (RRGB) Fiscal Q2 2026 Earnings Call: Margin Gains and Refranchising Progress

Red Robin’s fiscal Q2 2026 earnings call covered 1.3% comparable sales growth, a 14.7% restaurant margin, $96 million of refranchising proceeds and maintained guidance.

Red Robin Gourmet Burgers Inc

TradingKey

Fri, Aug 14

ROC Q2 2026 Earnings Call: Revenue Nearly Doubles Sequentially, Gross Margin Reaches 90%

ROC’s Q2 2026 earnings call covered $5.1 million in revenue, 41% R&D contract growth, a 90% gross margin and improving government activity.

TradingKey

Fri, Aug 14

Rockwell Medical (RMTI) Q2 2026 Earnings Call: Sales Rise 11%, Margin Expands

Rockwell Medical’s Q2 2026 sales rose 11% to $17.8 million, gross margin reached 18%, and management reaffirmed its full-year guidance.

Rockwell Medical Inc

TradingKey

Fri, Aug 14

Reed's (REED) Q2 2026 Earnings Call: Margin Improves, Financing Reviewed

Reed's Q2 2026 sales were $7.5 million, gross margin rose to 24%, and net loss narrowed 29% as it cut write-offs and evaluated financing.

TradingKey

Fri, Aug 14

REKR Q2 2026 Earnings Call: Recurring Revenue Growth and H2 Profitability Target

REKR Q2 2026 earnings call: revenue rose 2% to $12.7 million, recurring revenue grew 14%, margins expanded, and management targeted H2 adjusted EBITDA profitability.

Rekor Systems Inc

TradingKey

Fri, Aug 14

Resideo (REZI) Fiscal Q2 2026 Earnings Call: Stand-Alone Outlook and Margin Risks

Resideo Q2 2026 earnings call: revenue rose 2%, adjusted EBITDA gained 19%, and stand-alone 2026 guidance targets up to $2.95 billion in revenue.

Resideo Technologies Inc

TradingKey

Fri, Aug 14

RADCOM (RDCM) Q2 2026 Earnings Call: Revenue Falls 33.4%, Revised Outlook Reaffirmed

RADCOM Q2 2026 revenue fell 33.4% to $11.8 million as deployments were delayed. The company reaffirmed its $57 million–$63 million outlook.

TradingKey

Fri, Aug 14

QT Imaging (QTI) Q2 2026 Earnings Call: Revenue Up 103%, $39M Guidance Reaffirmed

QT Imaging Q2 2026 revenue rose 103% to $7.4 million on 15 scanner shipments, while management reaffirmed approximately $39 million in 2026 revenue.

QT Imaging Holdings Inc

TradingKey

Fri, Aug 14

Quantum SI (QSI) Q2 2026 Earnings Call: Proteus Launch Moved to Q2 2027

Quantum SI Q2 2026 earnings call: Proteus shifts to Q2 2027, revenue falls to $344,000, and cost cuts extend the expected cash runway into Q4 2028.

TradingKey

Fri, Aug 14

PolyPid (PYPD) Q2 2026 Earnings Call: D-PLEX100 Priority Review and Azurity Deal

PolyPid’s Q2 2026 earnings call covered D-PLEX100 Priority Review, a November PDUFA date, the Azurity deal, a narrower net loss and cash runway into 2028.

TradingKey

Fri, Aug 14

PodcastOne (PODC) Fiscal Q1 2027 Earnings Call: Record Revenue and EBITDA Growth

PodcastOne (PODC) fiscal Q1 2027 earnings call: record $16.1M revenue, $1.6M adjusted EBITDA, $7M cash, no debt and video-led growth.

TradingKey

Fri, Aug 14

Pelthos Therapeutics (PTHS) Q2 2026 Earnings Call: Revenue Rises 45%

Pelthos Therapeutics’ Q2 2026 earnings call covers $15.4 million in net product revenue, 48% prescription growth and planned 2027 product launches.

Pelthos Therapeutics Ord Shs

TradingKey

Fri, Aug 14

Paysafe (PSFE) Q2 2026 Earnings Call: Revenue Rises 4%, Deleveraging in Focus

Paysafe’s Q2 2026 earnings call covered 4% revenue growth, lower adjusted EBITDA, stronger Merchant Solutions results and a continued focus on deleveraging.

TradingKey

Fri, Aug 14

Protalix BioTherapeutics (PLX) Q2 2026 Earnings Call: Elfabrio Drives Revenue Growth

Protalix BioTherapeutics Q2 2026 revenue rose 26.8% to $19.9 million as Elfabrio drove growth, while management reaffirmed its full-year outlook.

Protalix Biotherapeutics Inc

TradingKey

Fri, Aug 14

Perma-Fix (PESI) Fiscal Q2 2026 Earnings Call: $6.2M Loss, Hanford Grouting Award

Perma-Fix Q2 2026 revenue fell to $12.9 million with a $6.2 million loss, while backlog grew and the company advanced its Hanford grouting program.

Perma-Fix Environmental Services Inc

TradingKey

Fri, Aug 14

PFG Q4 Fiscal 2026 Earnings Call: FY2027 Adjusted EBITDA Guided to $2.125B-$2.225B

PFG’s fiscal Q4 2026 earnings call covered 6.4% sales growth, $587.5 million adjusted EBITDA and fiscal 2027 guidance of up to $2.225 billion.

Performance Food Group Co

TradingKey

Fri, Aug 14

Pelagos Insurance Capital (PLGO) Q2 2026 Earnings Call: Premium Growth, Large Losses and Outlook

Pelagos Insurance Capital’s Q2 2026 earnings call covered 6% premium growth, a 99.5% combined ratio, $162 million of large losses and maintained 2026 targets.

Fidelis Insurance Holdings Ord Shs

TradingKey

Fri, Aug 14

PetMed Express (PETS) Fiscal Q1 2027 Earnings Call: Sales Stabilize Above $40 Million

PetMed Express (PETS) fiscal Q1 2027 earnings call: sales fell 19.9% to $41 million, net loss narrowed, and customer acquisition costs declined 15%.

Petmed Express Inc

TradingKey

Fri, Aug 14

1...27 28 29

29/37

Featured Tools

marketing_marketsTitle

calendar_economicCalendar

Economic Calendar

search.intelligent.strategy

article_asider_weekly_report

Popular Instruments

link

Name

Price

Chg%

link

Meta Q3 Net Profit Surges 264% YoY, Raises Full-Year Capex Slightly; Shares Briefly Rise Over 4% After Hours

Tesla Q3 Operating Profit Plunges 56% YoY, Dragged Down by Higher Operating Expenses Including R&D

Meta Q3 2026 Earnings: Legal Charge Halves Operating Margin Despite 26% Revenue Growth

US Stocks Close: Nasdaq Gains Over 1%, Philadelphia Semiconductor Index Rises Nearly 2%; Tech Stocks Strengthen, SpaceX Gains Nearly 8% Post-Earnings

Meta Q3 Earnings Preview: Muse Commercialization Faces Test, Wall Street High Target Price Hits $1,000

link

Silver/AUD (XAGAUD) Is down 2.12% on Oct 22: What Is Driving the Move?

an hour ago

Micro Silver (XAGUSD-M) Moved Sharply on Oct 22: Inventories, the Dollar, or Geopolitics?

2 hours ago

Silver (XAGUSD) Drops on Oct 22: What Lie behind the Move?

2 hours ago

Palladium (XPDUSD) Is down 2.53% on Oct 22: Is the Market Repricing It?

2 hours ago

Bitcoin (BTCUSD) Volatility Intensified on Oct 22: What You Should Know

2 hours ago